The role of haematological factors in diabetic peripheral arterial disease: the Edinburgh Artery Study

被引:37
|
作者
Lee, AJ
MacGregor, AS
Hau, CM
Price, JF
Rumley, A
Lowe, GDO
Fowkes, FGR
机构
[1] Univ Edinburgh, Dept Publ Hlth Sci, Wolfson Unit Prevent Peripheral Vasc Dis, Edinburgh EH8 9AG, Midlothian, Scotland
[2] Univ Glasgow, Royal Infirm, Dept Med, Haemostasis Thrombosis & Vasc Med Unit, Glasgow G31 2ER, Lanark, Scotland
关键词
peripheral arterial disease; haematological factors; diabetes; impaired glucose tolerance; fibrinogen;
D O I
10.1046/j.1365-2141.1999.01382.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between haematological factors and peripheral arterial disease (PAD) among diabetics has not been widely examined. 1592 men and women aged 55-74 years were selected from the general population, They underwent an assessment for PAD and a glucose tolerance test. 288 subjects (18.7%) were identified as having diabetes or impaired glucose tolerance (IGT), Among the diabetes/IGT group, median levels of fibrinogen, von Willebrand factor (VWF), tissue plasminogen activator (t-PA), fibrin D-dimer and plasma viscosity were higher in subjects with PAD than those without PAD (P less than or equal to 0.05). The prevalence of PAD was higher in those with diabetes/IGT (20.6%) compared to those with normal glucose tolerance (12.5%) (odds ratio 1.64: 95% CI 1.17, 2.31). After separate adjustment for fibrinogen, VWF, t-PA, fibrin D-dimer, leucocyte elastase, plasma viscosity and haematocrit, those with diabetes/IGT no longer had a significantly higher risk of PAD compared to those with a normal glucose tolerance test. Simultaneous adjustment for the first four of these haematological factors reduced the risk of PAD among subjects with diabetes/IGT to 1.11 (95% CI 0.76, 1.63). Increased levels of haemostatic factors may partly explain the higher prevalence of PAD in diabetic/IGT subjects compared to normal glucose-tolerant subjects. Future randomized controlled trials involving the indirect lowering of levels of haematological factors should help to explain whether the associations reported here are of causal significance.
引用
收藏
页码:648 / 654
页数:7
相关论文
共 50 条
  • [41] Growth Factor Deregulation and Emerging Role of Phosphatases in Diabetic Peripheral Artery Disease
    Mercier, Clement
    Rousseau, Marina
    Geraldes, Pedro
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 7
  • [42] Relationship of arterial stiffness to subclinical atherosclerosis and cardiovascular risk factors in an elderly cohort: Edinburgh Artery Study
    Lee, AJ
    Wilkinson, IB
    Smith, FB
    Webb, DJ
    Fowkes, G
    CIRCULATION, 2003, 107 (07) : E7034 - E7034
  • [43] Transcatheter Arterial Infusion of Autologous CD133+ Cells for Diabetic Peripheral Artery Disease
    Zhang, Xiaoping
    Lian, Weishuai
    Lou, Wensheng
    Han, Shilong
    Lu, Chenhui
    Zuo, Keqiang
    Su, Haobo
    Xu, Jichong
    Cao, Chuanwu
    Tang, Tao
    Jia, Zhongzhi
    Jin, Tao
    Uzan, Georges
    Gu, Jianping
    Li, Maoquan
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [44] Comparative study of angiographic changes in diabetic and non-diabetic patients with peripheral arterial disease
    Trainotti, Giovanni Ortale
    Mariuba, Jamil Victor
    Bertanha, Matheus
    Sobreira, Marcone Lima
    Yoshida, Ricardo de Alvarenga
    Jaldin, Rodrigo Gibin
    de Camargo, Paula Angeleli Bueno
    Yoshida, Winston Bonetti
    JORNAL VASCULAR BRASILEIRO, 2023, 22
  • [45] Risk factors for peripheral artery disease and diabetic peripheral neuropathy among patients with type 2 diabetes
    Chen, Tian
    Xiao, Shengjue
    Chen, Zhengdong
    Yang, Yiqing
    Yang, Bingquan
    Liu, Naifeng
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 207
  • [46] STUDY OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH PERIPHERAL ARTERY DISEASE
    Ceasovschih, A.
    Sorodoc, V.
    Aursulesei, V.
    Tesloianu, D.
    Jaba, I. M.
    Cozma, C. Dima
    Mihai, B.
    Statescu, C.
    Lionte, C.
    Sirbu, O.
    Stoica, A.
    Vata, L. G.
    Coman, A.
    Bologa, C.
    Haliga, R.
    Puha, G.
    Dumitrescu, G.
    Constantin, M.
    Simionov, L.
    Sorodoc, L.
    ATHEROSCLEROSIS, 2019, 287 : E190 - E190
  • [47] The interventional therapy for diabetic peripheral artery disease
    Sun, Nian-feng
    Tian, Ai-ling
    Tian, Yu-ling
    Hu, San-yuan
    Xu, Li
    BMC SURGERY, 2013, 13
  • [48] The role of cilostazol for peripheral arterial disease
    Amendt, K.
    Hsu, E.
    Gomer, M.
    Ruemenapf, G.
    GEFASSCHIRURGIE, 2008, 13 (03): : 171 - +
  • [49] Role of lipoprotein (a) in peripheral arterial disease
    Kosmas, Constantine E.
    Silverio, Delia
    Sourlas, Andreas
    Peralta, Richard
    Montan, Peter D.
    Guzman, Eliscer
    Garcia, Mario J.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [50] The interventional therapy for diabetic peripheral artery disease
    Nian-feng Sun
    Ai-ling Tian
    Yu-ling Tian
    San-yuan Hu
    Li Xu
    BMC Surgery, 13